CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 71 enrolled
Drug / intervention
BioWick SureLock Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03199391
NCT03199391N/ACompleted
CompareCT.gov

Efficacy of the BioWick SureLock Implant for the Reattachment of Soft Tissue to Bone in Subjects Undergoing Rotator Cuff Repairs

Zimmer Biomet·interventional·Posted Jun 26, 2017·Updated Jul 7, 2022

In Brief

A clinical study evaluating BioWick SureLock Implant for Rotator Cuff Tear. Completed, enrolled 71 participants across 7 sites.

Detailed Summary

The purpose of this study is to collect postmarket data in subjects who receive surgical treatment of a full-thickness rotator cuff tear (of at least 1.5 cm) with the BioWick™ SureLock™ implant. Both performance and safety data will be collected.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRotator Cuff Tear
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 26, 2017
Enrollment StartApr 26, 2017
Primary CompletionMay 5, 2021
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 9.0 years ago

Interventions

BioWick SureLock Implantdevice

The BioWick SureLock implant is a device for shoulder and extremity surgery, constructed of Ultra High Molecular Weight Polyethylene Suture. BioWick SureLock is uniquely designed to minimize these risks by avoiding manual tensioning with an inserter mechanism that ensures that the implant is consistently deployed below the cortex.